Study of ARO-DIMERPA for high triglycerides and cholesterol
Part of Genetic & congenital, Hormones & metabolism clinical trials.
This trial tests an experimental drug, ARO-DIMERPA, for people with very high triglycerides and cholesterol. It aims to lower those levels and reduce heart risks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be willing to follow diet advice from your doctor.
- Your fasting triglycerides, LDL cholesterol, and other fat levels must be above certain limits.
- If you could have a baby, you must use effective birth control plus a condom, and not donate sperm or eggs during the study and for 90 days after.
- You cannot have used certain RNA-based drugs or PCSK9 inhibitors recently.
- You must not have uncontrolled high blood pressure, a bleeding disorder, or nephrotic syndrome.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational medication, MAR001, to see if it can lower high levels of fats in the blood (triglycerides and remnant cholesterol) linked to heart disease. If you have these conditions, this treatment might help reduce your risk.
This trial tests a new medication called RBD5044 for people with mixed dyslipidemia (high levels of fats and cholesterol in the blood). It may help lower triglycerides and cholesterol when statins aren't enough.
This trial tests a new medication, SHR-1918, to lower high triglyceride levels. It may be an option for people with moderately elevated triglycerides and controlled cholesterol.
This study tests an oral medicine (HRS-5346) to lower lipoprotein(a), a type of fat in the blood linked to heart problems. It might help people with high levels who are at increased risk for heart attacks or strokes.
This study tests an experimental drug called DR10624 compared to a placebo in people with severely high triglycerides (fats in the blood). It aims to see if the drug can safely lower these fats and reduce the risk of related health problems like pancreatitis.
This study tests an experimental drug called HRS-1301 to see if it safely lowers LDL ("bad") cholesterol in people with high cholesterol. It is for adults who either already have artery disease or are at higher risk for it.
Hear when a new Hyperlipidemia; Mixed trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.